Categories AlphaGraphs, Earnings, Finance
SCHW Earnings: Charles Schwab reports higher revenue and adj. profit for Q4 2024
Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Tuesday reported double-digit growth in revenues and adjusted profit for the fourth quarter of 2024.
Total revenues increased 20% year-over-year to $5.33 billion in the December quarter. The topline benefitted from strong client engagement, increased margin utilization, and positive client cash trends.
Net income available to common stockholders was $1.72 billion or $0.94 per share in Q4, compared to $926 million or $0.51 per share in the prior-year quarter. Adjusted profit climbed 49% year-over-year to $1.01 per share during the three months.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
